Author:
Poole-Wilson Philip A,Lubsen Jacobus,Kirwan Bridget-Anne,van Dalen Fred J,Wagener Gilbert,Danchin Nicolas,Just Hanjörg,Fox Keith AA,Pocock Stuart J,Clayton Tim C,Motro Michael,Parker John D,Bourassa Martial G,Dart Anthony M,Hildebrandt Per,Hjalmarson Åke,Kragten Johannes A,Molhoek G Peter,Otterstad Jan-Erik,Seabra-Gomes Ricardo,Soler-Soler Jordi,Weber Simon
Reference21 articles.
1. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial;Lancet,2002
2. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients;Heart Outcomes Prevention Evaluation Study Investigators;N Engl J Med,2000
3. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study);EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease investigators;Lancet,2003
4. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease;Furberg;Circulation,1995
5. Corrections to the nifedipine meta-analysis;Furberg;Circulation,1996